| Gastric Varices Treatment: Coil + Cyanoacrylate Versus Cyanoacrylate (NCT02115061) | University of Sao Paulo General Hospital | 2013-08-01 |
| Compare the Same Dosage of Insulin Using a Combination of Cartridges, 30 Units as 2 Cartridges vs. 1 Cartridge (NCT01902121) | Mannkind Corporation | 2013-08-01 |
| A Phase I Study of AK159 in Healthy Postmenopausal Women (NCT01935479) | Asahi Kasei Therapeutics Corporation | 2013-08-01 |
| Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS) (NCT01890837) | Tsumura USA | 2013-08-01 |
| Partial Replicated Crossover Clinical Study to Compare Pharmacokinectic Characteristics of Eperisone Hydrochloride and Aceclofenac With HCP1104 Treatment to Those of Co-administration of Eperisone Hydrochloride 50mg Tablet and Aceclofenac 100mg Tablet in Healthy Adult Male Volunteers (NCT01869985) | Hanmi Pharmaceutical Company Limited | 2013-08-01 |
| Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in Humans (NCT01790451) | Clinical Research Office of the Endourological Society | 2013-08-01 |
| A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA) (NCT01925157) | Eli Lilly and Company | 2013-08-01 |
| A Trial Investigating the Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in a Tablet Formulation With Three Different Coatings in Healthy Subjects (NCT01931137) | Novo Nordisk A/S | 2013-08-01 |
| Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal Function (NCT01923857) | Repros Therapeutics Inc. | 2013-08-01 |
| Effects of Transvenous Vagus Nerve Stimulation on Immune Response: a Pilot Study (NCT01944228) | Medtronic Cardiac Rhythm and Heart Failure | 2013-08-01 |
| Single Ascending-dose Study of the Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Subjects (NCT01922661) | Regeneron Pharmaceuticals | 2013-08-01 |
| Use of Autologous Bone Marrow Aspirate Concentrate in Painful Knee Osteoarthritis (NCT01931007) | Mayo Clinic | 2013-08-01 |
| Phase II Part 2 Expansion of Oral Rigosertib in Combination With Azacitidine (NCT01926587) | Traws Pharma, Inc. | 2013-08-01 |
| AMES Treatment of the Proximal Arm in Chronic Stroke (NCT01934439) | Oregon Health and Science University | 2013-08-01 |
| Study to Evaluate the Effect of Single Doses of LX4211 and Canagliflozin on Intestinal Glucose Absorption in Healthy Adult Subjects (NCT01916863) | Lexicon Pharmaceuticals | 2013-08-01 |
| Long Term Safety Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study (NCT02002936) | SymBio Pharmaceuticals | 2013-08-01 |
| Effect of Food on Pharmacokinetics of Obeticholic Acid (OCA) (NCT01914562) | Intercept Pharmaceuticals | 2013-08-01 |
| Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis (NCT01935856) | Kyowa Kirin Co., Ltd. | 2013-08-01 |
| Safety and Pharmacokinetic(PK) Study of GW003 to Metastatic Tumors (NCT02156388) | Jiangsu T-Mab Biopharma Co.,Ltd | 2013-08-01 |
| A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma. (NCT01928368) | Amgen | 2013-08-01 |
| Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT01936090) | Mayo Clinic | 2013-08-01 |
| Retrain Your Brain in Children/Adolescents With Bipolar Disorder: A Pilot Study (NCT01954680) | Bradley Hospital | 2013-08-01 |
| A Multicenter Phase I Study Evaluating the Addition of Bortezomib to an Established Acute Graft Versus Host Disease Prophylaxis Regimen in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients (NCT01926899) | Indiana University | 2013-08-01 |
| FAST-Fish -Food Allergy Specific Treatment for Fish Allergy. (NCT02017626) | Rigshospitalet, Denmark | 2013-08-01 |
| Dysport for the Treatment of OMD (NCT01921270) | Emory University | 2013-08-01 |
| The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial (NCT01943136) | Philippine Dermatological Society | 2013-08-01 |
| Effect of Gastric Balloon in Morbid Obesity: Prospective Study (NCT02128165) | Mansoura University | 2013-08-01 |
| Pharmacokinetics of IDX719 in Participants With Normal and Impaired Hepatic Function (MK-1894-008) (NCT01919125) | Merck Sharp & Dohme LLC | 2013-08-01 |
| Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma. (NCT01993784) | Peking University | 2013-08-01 |
| Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma (NCT01920191) | University Hospital, Geneva | 2013-08-01 |
| Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma (NCT01590160) | University College, London | 2013-08-01 |
| Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors (NCT01804530) | Plexxikon | 2013-08-01 |
| A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma (NCT02076646) | Philogen S.p.A. | 2013-07-31 |
| A Phase I/II Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) (NCT02957019) | Philogen S.p.A. | 2013-07-31 |
| Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma (NCT01916187) | NCIC Clinical Trials Group | 2013-07-30 |
| DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT01834248) | Roswell Park Cancer Institute | 2013-07-30 |
| Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) (NCT01918761) | Central European Cooperative Oncology Group | 2013-07-30 |
| A Phase I Trial to Assess the Effects of Food and Formulation on PK of KPT-330 in Patients With Sarcoma (NCT01896505) | Karyopharm Therapeutics Inc | 2013-07-30 |
| Study to Determine the Intra-subject Variability of Pharmacokinetics of Lomitapide in Healthy Subjects (NCT01915771) | Aegerion Pharmaceuticals, Inc. | 2013-07-29 |
| Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC) (NCT01822613) | Novartis Pharmaceuticals | 2013-07-26 |
| Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers (NCT01932437) | Elusys Therapeutics | 2013-07-26 |
| Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors (NCT01751425) | M.D. Anderson Cancer Center | 2013-07-24 |
| Safety, Tolerability and PK of Repeat Administration of Intravenous ETI-204 in Adult Volunteers (NCT01932242) | Elusys Therapeutics | 2013-07-23 |
| Pre-Operative Radiation and Veliparib for Breast Cancer (NCT01618357) | Richard Zellars | 2013-07-22 |
| Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines (NCT01905215) | GlaxoSmithKline | 2013-07-22 |
| Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome (NCT01893320) | M.D. Anderson Cancer Center | 2013-07-18 |
| Systemic Therapy With Interferon, Interleukin-2 and BRAF Inhibitor (NCT01603212) | M.D. Anderson Cancer Center | 2013-07-18 |
| A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma (NCT01790503) | Daiichi Sankyo | 2013-07-18 |
| Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas (NCT01897012) | National Cancer Institute (NCI) | 2013-07-17 |
| A Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer or Non-small Cell Lung Cancer (NCT01862081) | Genentech, Inc. | 2013-07-16 |
| Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas (NCT01898078) | Millennium Pharmaceuticals, Inc. | 2013-07-16 |
| Pharmacokinetic Study in Healthy Volunteers to Characterise the Exposure of Fluticasone Furoate (FF), Vilanterol (VI) and Umeclidinium (UMEC) at Two Different Doses (NCT01894386) | GlaxoSmithKline | 2013-07-15 |
| Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult Volunteers (NCT01890785) | Shire | 2013-07-15 |
| TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas (NCT01851369) | National Cancer Institute (NCI) | 2013-07-12 |
| Phase I/II Study of Treg/Tcon Addback to Partially Matched Related Donor Stem Cells With Myeloablative Conditioning and Post-transplant Cyclophosphamide for High Risk Hematologic Malignancies (NCT01818479) | University of Utah | 2013-07-12 |
| Open-label Investigation of the Safety and Clinical Effects of NTCELL in Patients With Parkinson's Disease (NCT01734733) | Living Cell Technologies | 2013-07-12 |
| Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery (NCT01835223) | Roswell Park Cancer Institute | 2013-07-11 |
| A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or Lymphomas (NCT01877382) | Daiichi Sankyo | 2013-07-11 |
| Evaluation of the Effects of Multiple Doses of Cebranopadol on the Electrical Activity of the Heart in Healthy Subjects (NCT03958123) | Tris Pharma, Inc. | 2013-07-10 |
| A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects. (NCT01899755) | GlaxoSmithKline | 2013-07-10 |
| AZD8186 First Time In Patient Ascending Dose Study (NCT01884285) | AstraZeneca | 2013-07-09 |
| Safety, Tolerability, and PK of a Single Intravenous Dose of ETI-204 in Adult Volunteers (NCT01929226) | Elusys Therapeutics | 2013-07-09 |
| CT Antigen TCR-redirected T Cells for Ovarian Cancer. (NCT01567891) | Adaptimmune | 2013-07-09 |
| The Effects of Minocycline in Humans (NCT02193269) | Yale University | 2013-07-08 |
| Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer (NCT01899989) | Memorial Sloan Kettering Cancer Center | 2013-07-05 |
| D081AC00001 Food Interaction With Olaparib Capsule in Patients With Solid Tumours (NCT01851265) | AstraZeneca | 2013-07-04 |
| Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study (NCT01891318) | Case Comprehensive Cancer Center | 2013-07-03 |
| Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia (NCT01861314) | National Cancer Institute (NCI) | 2013-07-03 |
| Black Raspberry Confection in Preventing Oral Cancer in Healthy Volunteers (NCT01961869) | Ohio State University Comprehensive Cancer Center | 2013-07-02 |
| Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases (NCT01843413) | Case Comprehensive Cancer Center | 2013-07-02 |
| Study of Acamprosate in Autism (NCT01813318) | Children's Hospital Medical Center, Cincinnati | 2013-07-02 |
| Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma (NCT01832727) | Amgen | 2013-07-02 |
| A Single-dose, Open-label, Parallel-group Study to Assess the Pharmacokinetics of BAF312 in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function (NCT01904214) | Novartis Pharmaceuticals | 2013-07-01 |
| A Study of Baricitinib and Birth Control Pills in Healthy Females (NCT01896726) | Eli Lilly and Company | 2013-07-01 |
| Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors. (NCT02058901) | Amsterdam UMC, location VUmc | 2013-07-01 |
| Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma (NCT01944982) | Hospital Infantil Universitario Niño Jesús, Madrid, Spain | 2013-07-01 |
| Pharmacokinetic Drug Interaction Between YH4808 and Diclofenac (NCT01876615) | Yuhan Corporation | 2013-07-01 |
| PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin (NCT01975961) | Yuhan Corporation | 2013-07-01 |
| The PK and PD Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects (NCT01921647) | Yuhan Corporation | 2013-07-01 |
| Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in Japan (NCT01896830) | Sanofi Pasteur, a Sanofi Company | 2013-07-01 |
| Bio-equivalence Study Between SAPHRIS and Asenapine (NCT01948024) | Sun Pharmaceutical Industries Limited | 2013-07-01 |
| A Study to Evaluate AZP531 in Healthy Volunteers, Overweight/Obese Volunteers and Patients With Type 2 Diabetes Mellitus (NCT02040012) | Alizé Pharma | 2013-07-01 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis (NCT01853033) | AbbVie | 2013-07-01 |
| Pharmacokinetics and Safety Study of ME1100 in Healthy Volunteers (NCT01907776) | Meiji Seika Pharma Co., Ltd. | 2013-07-01 |
| CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer (NCT01839981) | Wake Forest University Health Sciences | 2013-07-01 |
| A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD) (NCT01886469) | Ironshore Pharmaceuticals and Development, Inc | 2013-07-01 |
| A Study in Stable Epilepsy Patients Comparing Brand and Generic Divalproex Sodium Extended Release Tablets (NCT01898676) | Vince & Associates Clinical Research, Inc. | 2013-07-01 |
| A Study to Assess the Relative Bioavailability of 4 New Abiraterone Acetate Tablet Formulations With Respect to the Current Commercial Abiraterone Acetate Tablet Under Fasted Conditions in Healthy Male Participants (NCT01897389) | Janssen Research & Development, LLC | 2013-07-01 |
| Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 (NCT02122822) | Cure&Sure Biotech Co., LTD | 2013-07-01 |
| Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Eperisone HCl SR Tablet 75mg (NCT01885520) | NVP Healthcare | 2013-07-01 |
| A Safety Study of SGN-CD33A in AML Patients (NCT01902329) | Seagen Inc. | 2013-07-01 |
| Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Subjects (NCT02083315) | Trevena Inc. | 2013-07-01 |
| Safety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy Adults (NCT01829490) | University of Oxford | 2013-07-01 |
| Characterization Of The Effect Of Food On Palbociclib (PD-0332991) Absorption (NCT01904747) | Pfizer | 2013-07-01 |
| Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma. (NCT01777776) | Array BioPharma | 2013-07-01 |
| A Crossover Study to Evaluate the Effect of JNJ-54452840 on Pharmacodynamics of Metoprolol Tartrate Immediate-Release in Healthy Participants (NCT01902550) | Janssen Research & Development, LLC | 2013-07-01 |
| Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe (NCT01890473) | Bristol-Myers Squibb | 2013-07-01 |
| Bioequivalence Study to Evaluate the Impact of Varying Crystalline Polymorph Forms for the Commercial Oral Capsule Formulation of 10-mg Lenvatinib in Healthy Volunteers (NCT02723630) | Eisai Inc. | 2013-07-01 |
| A(H7N9) VLP Antigen Dose Ranging Study With Adjuvant 1 (NCT01897701) | Novavax | 2013-07-01 |
| Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients (NCT01894906) | Rockwell Medical Technologies, Inc. | 2013-07-01 |